RRx-001 followed by platinum plus etoposide in patients with previously treated small-cell lung cancer

BACKGROUND: This exploratory single-arm phase II study evaluated the efficacy and safety of RRx-001 followed by reintroduction of platinum plus etoposide in patients with previously treated small-cell lung cancer (SCLC). METHODS: Patients were treated with RRx-001 4 mg IV on day 1 of each week of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Morgensztern, Daniel, Rose, Michal, Waqar, Saiama N., Morris, John, Ma, Patrick C., Reid, Thomas, Brzezniak, Christina E., Zeman, Karen G., Padmanabhan, Arvinda, Hirth, JoAnn, I. Spira, Alexander, Trepel, Jane B, Padda, Sukhmani K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738071/
https://www.ncbi.nlm.nih.gov/pubmed/31231122
http://dx.doi.org/10.1038/s41416-019-0504-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738071/
https://www.ncbi.nlm.nih.gov/pubmed/31231122
http://dx.doi.org/10.1038/s41416-019-0504-8

Ejemplares similares